media – Page 575 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

Newly FDA-Approved Platform Will Rapidly “Manufacture” Stem Cells to Repair Our Bodies

Stem cells have the unique capability to transform into any sort of specialized cell needed in the body, making them especially promising for medicine that replaces nonfunctional or dead cells.
- Source: Futurism
- 490
- January 16, 2018
FDA New Approvals stem cells
FDA approves algorithm that predicts sudden patient deaths to help prevent them

Wave Clinical Platform is the work of ExcelMedical and is a system that monitors patients' vital signs, sending alerts that warn of potentially fatal heart attacks or respiratory failure up to six hours before a patient suffers such an event.
- Source: Digital Trends
- 509
- January 16, 2018
FDA healthcare technology New Approvals
Genentech beefs up its PD-L1 combo pipeline, signing the ‘don’t eat me’ specialists at Forty Seven

After expanding its partnership with Syndax $SNDX earlier this week on their lead drug, Genentech has beefed up their pipeline of PD-L1 combos with a fresh pact with Stanford spinout Forty Seven.
- Source: Endpts;
- 374
- January 15, 2018
Market Views PD-L1 combos
FDA approves first treatment for breast cancer with a certain inherited genetic mutation

The U.S. Food and Drug Administration today expanded the approved use of Lynparza (olaparib tablets) to include the treatment of patients with certain types of breast cancer that have spread (metastasized) and whose tumors have a specific inherited (germline) genetic mutation, making it the first drug in its class (PARP inhibitor) approved to treat breast cancer, and it is the first time any drug has been approved to treat certain patients with metastatic breast cancer who have a "BRCA" gene mutation. Patients are selected for treatment with Lynparza based on an FDA-approved genetic test, called the BRACAnalysis CDx.
- Source: finance.yahoo
- 549
- January 15, 2018
breast cancer Lynparza metastasized New Approvals
Alveo Closes $38 Million in Series A Financing to Create Accessible Diagnostics Devices

Alveo Technologies, Inc., ("Alveo" or "the Company") whose mission it is to create affordable and accessible infectious disease diagnostic devices, announced the closing of a $38 million Series A financing raised by Maxim Merchant Capital, a division of Maxim Group LLC. The round was oversubscribed and included existing and new investors. The offering proceeds will be used to advance the optimization and commercialization of Alveo's rapid diagnostic platform for infectious diseases.
- Source: Prnewswire
- 401
- January 15, 2018
infectious diseases Market Views Series
NHS to support 138 entrepreneurs on new medical technologies

The National Health Service (NHS) in the UK is set to support 138 entrepreneurs among its staff, through its clinical entrepreneurs’ programme, in the design and development of new healthcare technologies and innovations.
- Source: medicaldevice-network
- 622
- January 15, 2018
healthcare technologies and innovations NHS polices
New IVF technique hailed as the ‘most exciting advance in fertility treatment for 40 years’

A new IVF method that takes thousands of pictures of embryos to select the best eggs has increased the likelihood of a baby being born by 25 percent.
- Source: Daily Mail
- 503
- January 15, 2018
IVF pregnancy Researches
New AI system for lung cancer and heart disease

Artificial intelligence is gradually being adopted by health services to assist medics with the diagnosis of serious diseases. In one new development, scientists in Oxford, U.K. have launched an AI system for heart disease.
- Source: Digital Journal
- 961
- January 15, 2018
AI heart attacks lung cancer Researches
UK Takes Stricter Stance on Human Factors Engineering for Medical Devices

Recent guidance from UK medical device market regulators on human factors engineering (HFE) includes some recommendations that differ from HFE requirements established in Europe, suggesting a more standalone British approach to some areas of device development.
- Source: Emergo
- 587
- January 15, 2018
FDA medical device Policy
New Version Active–Check out the New Features of Ddu V3.0

Ddu V3.0 is finally online. Let’s check out the new functions!
- Source: Ddu
- 937
- January 12, 2018
Ddu News

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.